MTOR and breast carcinoma: In the present study, for the first time, membrane remodeling is followed up together with EGFR, AKT and mTOR protein expressions and activation during SA supplementation in three breast cancer cell lines (MCF-7, MDA-MB-231, BT-20) chosen for their different characteristics of hormone responders and resistance.